Navigation Links
New study of Concerta showed significant improvement of ADHD symptom management in adults
Date:10/26/2007

Boston, Mass., Friday Oct. 26, 2007 11:00AM Adults with Attention Deficit Hyperactivity Disorder (ADHD) treated with CONCERTA OROS methylphenidate HCl Extended-release Tablets showed significant improvements in ADHD symptom management compared to adults taking placebo, according to study results presented today at a major psychiatric medical meeting.

Pharmacological treatment of children and adolescents with ADHD is clearly established but relatively less is known about the treatment of adults with ADHD, notes the studys medical director, Sally Berry, M.D., PhD., of Johnson & Johnson Pharmaceutical Research and Development, LLC. Were encouraged that the CONCERTA findings presented today -- in which CONCERTA significantly improved ADHD symptom management in adults -- can benefit the growing body of knowledge in this important therapeutic area.

The data presented today are part of a Supplemental New Drug Application (sNDA) submitted in August 2007 to the Food and Drug Administration for use of CONCERTA to treat adults with ADHD. CONCERTA is already approved for the treatment of ADHD in children and adolescents ages six to 17.

About the Study

In the study presented today, efficacy was measured as a change in the Adult ADHD Investigator Symptom Rating Scale (AISRS) total score. The results showed that CONCERTA achieved a significantly superior reduction in AISRS total score compared to placebo (p=0.012) (mean change was -10.6 1.09 for the CONCERTA group vs. -6.8 1.06 for the placebo group.

In addition, CONCERTA was significantly superior compared to placebo for the key secondary efficacy variables: change in Clinical Global Impression-Improvement (CGI-I) rating (p=0.008); change in Conners Adult ADHD Rating Scale-Self Report (CAARS-S:S) total score (p=0.029) and change in percent of subjects meeting pre-defined Responder criteria (p=0.009).

In the study, 229 patients with ADHD aged 18-65 years were randomized
'/>"/>

Contact: Tricia Geoghegan
tgeogheg@janus.jnj.com
609-462-8764
Golin/Harris International
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Rural Canadians travel far for specialists: study
2. A new study surpasses Gene Therapy Hurdle
3. Tomato Sauce reduces Cancer Risk- Study
4. A question on study of Adult Stem Cell
5. Study on obesity and heart failure
6. National Lung Study in the process
7. Marijuana gateway theory strengthened by study of twins
8. Old theory of adaptation confirmed by new study
9. Study casts doubt on keyboard ills
10. Gene study links endometriosis, infertility
11. Study reveals how stress can make you sick

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...7 GSI Group Inc. (Pink S...ion technology products and semiconductor systems,...pany,s shareholders has been scheduled for Friday,...ting will be announced in due course. As previous...otice from Stephen Bershad, a holder of greater th...
(Date:11/27/2009)...PRNewswire-FirstCall/ -- The Gymboree Corporation .../COO, will present at the NASDAQ OMX 23rd Investor... in London, England, on Wednesday, December 2, 200...oadcast of The Gymboree Corporation,s presentation...com, click on "Our Company" at the bottom of the p...
(Date:11/27/2009)...Holdings has announced that it has become a nation... largest nonprofit organizations dedicated to arth... Delray Beach, FL (Vocus) Nove...CHO), a company specializing in the marketing and ...s, has announced today that is has become a nation...
(Date:11/27/2009)...alth™ announced today that Spectrum Health (... Enterprise orthopedic templating solution and its... (PRWEB) November 27, 2009 -- Voyant ... (Grand Rapids, Michigan) has licensed its TraumaC...ts TraumaCad Extend workflow solution, to allow it...
(Date:11/26/2009)...wswire/ -- With cold and flu season upon us, it,s ...to control the spread of infections and avoid illn...ep ourselves healthy, but to avoid transmitting il... CIC (certified in infection-control), nursing dir...h at Hospital for Special Surgery (HSS) in Manhatt...
Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4
...developed a gel that it says can treat hypogonadis...dism is a condition that causes reduced libido, er...y, and irritability. Like women who grow l... male libido and sexual function, as well as muscl...
...nown for its religious fervour, is emerging as a h...s as Astrology Doctors . Many claim that t... kidney-related problems and others, with their ge...tones are prescribed for patients after studying t...
...as found that diabetes is associated with decrease... developing heart disease . The study, pub...e JAMA/Archives journals, shows that men and women...ut diabetes. Globalization of the Western ...
...search team has identified a gene that, when mutat...rited blindness in babies . Scientists at ...experts from other centres around the world, disco...rs congenital amaurosis (LCA), comes at a time of ...
...iyo Mori said Monday she had confidence in herself...onal Japanese women who are often seen as timid. ... to Japan," Mori, 20, told her first news conferen...Fuji last month became the second Japanese to be c...
...cessfully eased the symptoms of Parkinson's diseas...splants . During the course of study, publ...f Sciences, the scientists isolated stem cells fro...monkeys with a severe form of chemically induced P...
Other Medicine News:Health News:Is Gemstone-therapy an Alternative to Treat Illness? 2Health News:Diabetes Reduces Life Expectancy, Increases Heart Disease Risk 2Health News:New Gene Discovery Raises Hope for Childhood Blindness Cure 2Health News:New Gene Discovery Raises Hope for Childhood Blindness Cure 3
(Date:11/29/2009)..., CHICAGO, Nov. 29 At the 95th...iological Society of North America (RSNA), "Images...lthcare booth (#825) from November 29 to December ...keside Center, Hall D) in Chicago. This year,s boo... of Siemens support for its customers to generate,...
(Date:11/29/2009)..., CHICAGO, Nov. 29 FUJIFILM Medic...D-EVO*, its revolutionary flat panel DR cassette, ...(RSNA) Annual Meeting. Ideal for any clinical env...ogy to provide clinicians with Fujifilm,s trademar..., D-EVO is a smart way for users to transition to...
(Date:11/29/2009)..., CHICAGO, Nov. 29 This year at t...ientific Assembly and Annual Meeting, FUJIFILM Med...he advanced visualization space with the introduct...ts core strength in image processing by now offeri...general radiographic and cardiovascular applicatio...
Breaking Medicine Technology:Siemens Delivers Images per the Customer's Request - 'Images My Way' 2Siemens Delivers Images per the Customer's Request - 'Images My Way' 3Siemens Delivers Images per the Customer's Request - 'Images My Way' 4Siemens Delivers Images per the Customer's Request - 'Images My Way' 5Siemens Delivers Images per the Customer's Request - 'Images My Way' 6Siemens Delivers Images per the Customer's Request - 'Images My Way' 7Siemens Delivers Images per the Customer's Request - 'Images My Way' 8Siemens Delivers Images per the Customer's Request - 'Images My Way' 9FUJIFILM's DR Cassette Makes World Debut 2FUJIFILM Enters Advanced Visualization Market 2FUJIFILM Enters Advanced Visualization Market 3FUJIFILM Enters Advanced Visualization Market 4Paul Marks prize recognizes 3 young cancer researchers 58437 1Paul Marks prize recognizes 3 young cancer researchers 58437 2Paul Marks prize recognizes 3 young cancer researchers 58437 3Paul Marks prize recognizes 3 young cancer researchers 58437 4Paul Marks prize recognizes 3 young cancer researchers 58437 5Study suggests obesity alone does not cause knee osteoarthritis in mice 58434 1Study suggests obesity alone does not cause knee osteoarthritis in mice 58434 2Institute for Aging Research study links high heels to heel and ankle pain 58431 1Institute for Aging Research study links high heels to heel and ankle pain 58431 2
...NNA, Va., Oct. 18 CEL-SCI CORPORATION,(Amex: CVM...r, Geert,Kersten, is a featured presenter at the I...g (ISPE) 2007 Chesapeake BioShowcase in,Gaithersbu...Realities for,Funding a Small Biotechnology Compan... April 2007, CEL-SCI completed a $15 million priva...
...LAS, Oct. 18 Access Pharmaceuticals, Inc.,(OTC Bu...borators will be,presenting clinical and preclinic...TM), at the joint symposium of the American Associ...Institute (NCI) and European,Organization for Rese...ernational Conference Molecular Targets and Cancer...
Other Medicine Technology:CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase 2Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC 'Molecular Targets and Cancer Therapeutics' Conference 2
SureStep Benzodiazepines (BZO 200)
SureStep Propoxyphene (PPX)
SureStep Tricyclic antidepressants (TCA)
THC/COC/MOP/AMPII/MAMPII/BZO200
Medicine Products: